ADVERTISEMENT
GRAFIX*
GRAFIX* cryopreserved placental membrane for wound management is composed of native living cells, growth factors, and extracellular matrix.
Smith+Nephew, Inc.
Smith+Nephew, Inc.
For over 150 years, Smith+Nephew has taken a pioneering approach to product design and services, helping to reduce the human and economic costs of wounds.
Advanced Wound Bioactives
(Includes Collagenase SANTYL* Ointment, PROSHIELD* Foam & Spray Incontinent & Total Body Cleanser, PROSHIELD* Plus Skin Protectant, REGRANEX* (becaplermin) Gel 0.01%)
Toll-free: (800) 441-8227
Fax: (817) 900-4100
Email: snbiocc@smith-nephew.com
Cellular- and/or Tissue-Based Products
(Includes GRAFIX PL*, GRAFIX*, STRAVIX*, OASIS® MICRO, OASIS® Wound Matrix, OASIS® Burn Matrix, and OASIS® Ultra Tri-Layer Matrix)
Website: www.stravixpl.com
Phone: (888) 674-9551
Fax: (443) 283-4419
Email: osiris-biosurgerycs@smith-nephew.com
Advanced Wound Care or Devices
(PICO* Single Use Negative Pressure Wound Therapy, RENASYS* TOUCH Negative Pressure Wound Therapy, RENASYS* GO Negative Pressure Wound Therapy)
Toll-free: (800) 876-1261
Fax: (727) 392-6914
Email: customercare.wound@smith-nephew.com
*Trademark of Smith+Nephew
1.5cmx2cm, 2cmx3cm, 3cmx4cm, 5cmx5cm. Round: 16mm.
• Can be used for acute and chronic wounds, diabetic ulcers, pressure injuries, surgical wounds, burns, and venous ulcers
• Flexible, conforming cover that naturally adheres to complex anatomies and may be used over exposed bone, tendon, joint capsule, muscle, and hardware
• Designed for application directly to acute and chronic wounds
• Immune neutral
• No need for sutures or Steri-Strips®
• Available in multiple sizes to reduce wastage
GRAFIX* is limited to the homologous use as a wound cover/wrap/barrier.
There are no known contraindications for GRAFIX*.
Intended for use in one patient, on a single occasion only.
Do not use if package integrity has been compromised. Once the user breaks the seal on the pouch, GRAFIX* must be transplanted or discarded.
GRAFIX* may not be sterilized.
GRAFIX* is intended for use by qualified health care specialists such as physicians, podiatrists, or other appropriate health care professionals.
The same medical/surgical conditions or complications that apply to any medical/surgical procedure may occur during or following application.
The health care professional is responsible for informing the patient of the risks associated with his/her treatment and the possibility of complications or adverse reactions.
Caution should be exercised for patients with known sensitivities for reagents used for processing, disinfection, and storage which may remain on the product.
Donor screening methods are limited; therefore, certain diseases may not be detected. The following complications of tissue transplantation may occur:
• Transmission of infectious agents or diseases of known or unknown etiology including, but not limited to fungi, bacteria, or viruses;
• Immune rejection of implanted GRAFIX*; or
• Loss of function and/or integrity of GRAFIX* due to resorption, fragmentation, and/or disintegration.
GRAFIX* has a 3 year shelf life and and should be stored frozen at -75°C to -85°C (-103°F to -121°F).
GRAFIX* can be applied in an office, hospital outpatient setting or in an operating room. GRAFIX* naturally conforms to complex anatomies and may be used over exposed bone, tendon, joint capsule, muscle, and hardware. GRAFIX* may be used to repair acute and chronic wounds, encompassing both upper extremity and lower extremity, including but not limited to: diabetic foot ulcers, venous leg ulcers, pressure injuries, dehisced surgical wounds, burns, acute surgical wounds, pyoderma gangrenosum, and epidermolysis bullosa.
TECHNICAL SPECIFICATIONS:
Donor eligibility is determined based on FDA screening and testing criteria, which includes testing for the following:
Human Immunodeficiency Virus Type 1 Antibody (HIV)
Human Immunodeficiency Virus Type 2 Antibody (HIV)
Hepatitis C Virus Antibody (HCV)
Hepatitis B Surface Antigen (HBV)
Hepatitis B Core Antibody (HBV)
Syphilis Rapid Plasma Reagin (RPR) or Treponemal Specific Assay
Human T-Cell Lymphotrophic Virus Type I Antibody (HTLV)
Human T-Cell Lymphotrophic Virus Type II Antibody (HTLV)
HIV/HCV/HBV Nucleic Acid Test (NAT)
West Nile Virus (WNV) Nucleic Acid Test (NAT)
Each lot must be sterility negative per USP
Live cells present across 70% of the membrane sampled
Growth factors are present in GRAFIX PRIME*
More Products
